Previous 10 | Next 10 |
Markets have settled and recovered from the initial shock of the coronavirus spread and the response of governments around the US and the world to lock down the economy. But while the major US indices have approached, if not quite matched, the fabled v-shaped recovery, there are still plenty o...
Markets have settled and recovered from the initial shock of the coronavirus spread and the response of governments around the US and the world to lock down the economy. But while the major US indices have approached, if not quite matched, the fabled v-shaped recovery, there are still plenty o...
Co-produced with Beyond Saving A great defense is a good offense. There are still many uncertainties in this market. The bullish rally could easily turn around from any little bit of negative news. Businesses are in the infancy stages of reopening, but how long will it take for consume...
An observational study involving COVID-19 patients treated at New York-Presbyterian Hospital-Columbia University Irving Medical Center did not show a treatment benefit from the use of malaria drug hydroxychloroquine. The results were just published in the New England Journal of Medicine ....
Author's note: This article was released to CEF/ETF Income Laboratory on April 28, 2020. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund [CEF] sectors in the last week, as well as to highlight recently co...
Co-produced with Treading Softly Often I get asked about various aspects of investing, but none seems to be as recurring as the usage of margin while dividend investing. It may come as a surprise to many of my readers but I do not actively engage in the use of margin to "juice" my return...
Co-produced with PendragonY Why Investors are Getting More Interested in Healthcare? First, the crisis has exposed two weaknesses within the United States including deep structural problems like a dysfunctional healthcare system and a lack of a social safety net. Even testing poten...
In a statement , the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart rhythm side effects. More news on: Tekla World Healthcare Fund, BlackRock Health Science...
Written by Nick Ackerman, co-produced by Stanford Chemist Throughout the massive COVID-19 selloff, Stanford Chemist and I have received several inquiries relating to the bankruptcy of closed-end funds or funds going "bust." As we aren't out of the woods yet with selloff pressures, now mi...
Former FDA Commissioner Scott Gottlieb, M.D. is joining the growing chorus of experts who believe that the actual number of COVID-19 infections in the U.S. is substantially higher than reported, as much as 20 times higher he says. More news on: Tekla World Healthcare Fund, BlackRock Health...
News, Short Squeeze, Breakout and More Instantly...
Tekla World Healthcare Fund Shares of Beneficial Interest Company Name:
THW Stock Symbol:
NYSE Market:
There’s nothing we closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount (of course!), plus a much bigger dividend, because yields and prices move in opposite directions. In fact, with CEFs, we...
Most investors are ignoring a clear shot at 7%+ dividends double-digit price gains—year in and year out—in a sector everyone should be talking about, but isn’t. That would be healthcare, which is riding a rocket of rising spending: according to the latest number...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...